BARCELONA, Spain—Placing dissolvable patches soaked in amiodarone on the heart’s surface at the end of elective cardiac ...
The results make the case for surgeons to be more involved in secondary prevention, especially with the PCSK9 inhibitor.
The TRIUMPH-2 and SYNCHRONIZE-2 studies show both novel agents to be highly effective, but some questions remain.
The expert consensus decision pathway goes beyond the guidelines to provide practice advice around BP management.
BARCELONA, Spain—The DEDICATE-DZHK6 trial comparing TAVI with SAVR in low-to-intermediate-risk German patients with aortic ...
The observational Swedish data need to be further explored but may have identified a new screening target in stroke ...
A postapproval study and a subgroup analysis of complex patients show high efficacy rates for the two limus-eluting ...
Observational studies from Spain, Italy, and the United States help paint a clearer picture of a growing field.
What's ahead at this year's TCT in San Diego? Roxana Mehran hears the highlights from Martin Leon and Juan Granada.
The evolving data now show clear biological efficacy with impact on hard clinical outcomes, says Sahil Parikh.